PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINING SINGLE-TABLET REGIMEN (D/C/F/TAF) COMPARED WITH OTHER MULTI-TABLET REGIMENS CONTAINING BOOSTED PROTEASE INHIBITORS (BPIS)

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1380
https://www.valueinhealthjournal.com/article/S1098-3015(18)34682-5/fulltext
Title : PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINING SINGLE-TABLET REGIMEN (D/C/F/TAF) COMPARED WITH OTHER MULTI-TABLET REGIMENS CONTAINING BOOSTED PROTEASE INHIBITORS (BPIS)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34682-5&doi=10.1016/j.jval.2018.09.1380
First page :
Section Title :
Open access? : No
Section Order : 764
Categories :
Tags :
Regions :
ViH Article Tags :